Research/Development

Israel-Hamas battle threatens tech sector development and innovation

Dialysis firm shares plunge after Ozempic trial success vs. kidney bother

Amgen to proceed to hunt full approval of Lumakras most cancers drug after FDA panel votes in opposition to it

Moderna reviews constructive outcomes for mixture flu and COVID vaccine

India, Vietnam and Mexico are selecting up the items of China’s damaged financial system

Intel’s inventory slides to turn into Dow’s worst as stock ‘air pocket’ overshadows AI chip rollouts

Roblox cancels videogame awards presentation after ‘potential safety concern’

Netflix criticized for posting AI jobs paying as much as $900,000 whereas writers and actors are on strike

First Citizens shares leap on SVB deal as Novartis inventory boosted by breast-cancer drug trial

Novartis will get constructive consequence from breast-cancer drug trial